Resurgence of COVID hits FTSE

The COVID-19 recovery is built on a very fragile foundation - it could take very little for a fresh outbreak to paralyse businesses again.

Downtrend 5

Although today should have marked a positive turning point for the markets as non-essential shops in Britain start trading again, Belgium, France and other European countries reopen their borders and many airlines restart flights from today, COVID 19 demonstrated that the recovery is built on a very fragile foundation and that it could take very little for a fresh outbreak to paralyse businesses again.

A few new cases that cropped up in a Beijing market late last week have already spread across half of the city and some districts are already bringing in restrictions on movement of people. The news is not only hitting British stocks but is also eroding faith in other European blue chips, particularly export oriented ones. In London metal producers, oil firms, retail shops and travel businesses are among the hardest hit stocks.

BP tackles long-term oil price changes

The sharp drop in Brent crude prices over the last five months was reflected in BP’s first quarter bottom line as the company took a charge of $17.5 billion because of lower oil prices. BP changed its long-term assumption for oil prices, forecasting that the price will be closer to $55 rather than the $70 previously predicted. This is still about 30% higher than today’s oil price.

EasyJet has started its first flights to Europe today but the stock traded lower as investors worried that the resurgence in the virus will dampen tourists’ travel plans.

Bunzl defies gravity

International distribution group Bunzl was the only FTSE 100 stock to trade higher as it managed to increase revenues in the first half of the year on deliveries of food and medical products. Shares jumped over 6% after the firm said its revenues are likely to increase by 6% in the first six months of the financial year.

More from FTSE 100

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.